Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Eiichi Nagura"'
Autor:
Kazuyuki Shimizu, Mitsuhiro Itagaki, Takaaki Chou, Atsushi Isoda, Kazutaka Sunami, Morio Sawamura, Yoshiaki Kuroda, Morio Matsumoto, Takayuki Saitoh, Kenshi Suzuki, Hideki Asaoku, Shuji Ozaki, Hirokazu Murakami, Naoki Takezako, Hiroshi Handa, Shotaro Hagiwara, Eiichi Nagura
Publikováno v:
Annals of hematology. 98(7)
In spite of recent development in the treatment armamentarium for multiple myeloma, overall survival (OS) still depends on risk status and sensitivity to treatment of each patient. We have evaluated the clinical relevance of the Revised International
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(13)
We studied the clinical effects of high-dose methotrexate(HD-MTX)combined with rituximab and vincristine in 5 elderly patients, aged 65-83 years, with diffuse large B-cell lymphoma of the central nervous system(DLBCL CNS). Patients aged 65- 71 years
Autor:
Fumihiko Nakamura, Morio Matsumoto, Takayuki Saitoh, Kayoko Murayama, Go Yamamoto, Eiichi Nagura, Hiroshi Handa, Kazuyuki Shimizu, Shuji Ozaki, Hirono Iriuchishima, Yoshihisa Nojima, Hirokazu Murakami, Jun Konishi
Publikováno v:
Acta Haematologica. 135:113-121
We investigated the treatment and outcome of Japanese patients with primary plasma cell leukemia (pPCL) in the era of novel agents and analyzed the risk factors affecting survival. Among 3,318 patients with symptomatic multiple myeloma (MM), 38 patie
Publikováno v:
Geriatrics and Gerontology International. 4:77-83
Background: Malnourishment is closely connected with poor health outcomes in frail elderly. However, the relative importance of specific nutritional predictors of mortality remains unclear in the Japanese population. We investigated the potent nutrit
Publikováno v:
Geriatrics and Gerontology International. 4:93-99
Background: Awareness and evaluation of individual nutritional status are required for optimal support of the elderly population. A Japanese Anthropometric Reference Data ( JARD 2001) was established as a new gold standard, however, its utility for v
Autor:
Atsushi Wakita, Hideo Takeyama, Masakazu Nitta, Hisami Yamao, Atsushi Ichikawa, Hidehiko Saito, Kohei Kawashima, Kazuyuki Shimizu, Osamu Kamiya, Harumitsu Mizuno, Eiichi Nagura, Masahide Kobayashi
Publikováno v:
Internal Medicine. 41:290-294
Objective A newly designed combination chemotherapy for multiple myeloma, MMCP [ranimustine (MCNU), melphalan (MPH), cyclophosphamide (CPM) and prednisolone (PSL)], was analyzed and compared with the results of our previous randomized trial of VMCP [
Autor:
Atsushi Wakita, Eiichi Nagura, Masakazu Nitta, Noriyuki Hirabayashi, Kohei Kawashima, Kazuyuki Shimizu, Hiroshi Sao, Hidehiko Saito, Hideki Takeyama
Publikováno v:
International Journal of Hematology. 74:205-208
We conducted a retrospective study of patients with IgG or IgA myeloma who attained plateau to evaluate the relationships between survival and posttreatment nadir M-protein levels and between survival and the response to treatment evaluated by the pe
Autor:
Kazutaka Sunami, Takayuki Saitoh, Shuji Ozaki, Hiroshi Handa, Naoki Takezako, Hideki Asaoku, Yoshiaki Kuroda, Kenshi Suzuki, Hirokazu Murakami, Shimizu Kazuyuki, Eiichi Nagura, Mitsuhiro Itagaki
Publikováno v:
Blood. 128:4436-4436
Multiple myeloma (MM) is a heterogeneous disease in the survival outcome due to the differences in disease-, patient-, and treatment-related prognostic factors. Recently, a Revised International Staging System (R-ISS) incorporating the original ISS s
Autor:
Masakazu Nitta, Hideo Takeyama, Noriyuki Hirabayashi, Atsushi Ichikawa, Kohei Kawashima, Toshihiko Shibata, Hidehiko Saito, Hiroshi Sao, Masahide Kobayashi, Osamu Kamiya, Eiichi Nagura, Harumitsu Mizuno, Kazuyuki Shimizu
Publikováno v:
Japanese Journal of Cancer Research : Gann
In the present study 142 patients with myeloma (102 with IgG M-protein and 40 with IgA) treated with either VMCP (65 patients) or MMCP (77 patients) as remission induction therapy were retrospectively analyzed. Response to treatment was evaluated in
Autor:
Hideo Takeyama, Yosihisa Morishita, Eiichi Nagura, Hidehiko Saito, Harumitsu Mizuno, Saburo Minami, Kohei Kawashima, Mitsune Tanimoto, Yokomaku S, Tomoki Naoe, Hisamitsu Suzuki, Yoko Shirokawa, Koichiro Nagata, Takuhei Murase, Hiroshi Sao, Noriyuyki Hirabayashi
Publikováno v:
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 36:52-58
In order to obtain the realistic background information on clinical features, and the present status of treatment and outcome in elderly patients with acute lymphoblastic leukemia (ALL), we carried out random survey of patients with ALL aged 60 or ov